OJSC Galichpharm

OJSC Galichpharm, also registered as JSC Galichfarm, is a pharmaceutical manufacturer headquartered in Ukraine. The enterprise specializes in the production of finished medicines and herbal extraction‑based phyto‑chemical substances. These veterinary‑oriented products are formulated for use in livestock health. A notable emphasis of its product portfolio is on swine‑specific medicinal preparations. The firm’s legal form as an open joint‑stock company is reflected in its OJSC/JSC designation.

Its core competency lies in the extraction of active compounds from plant material to create phyto‑chemical ingredients for animal medicines. This focus on natural‑derived veterinary agents distinguishes it from manufacturers that rely chiefly on synthetic active pharmaceutical ingredients. Consequently, the company’s market reach is confined to the veterinary sector, serving distributors and farms that require swine‑health products. In January 2023, JSC Galichfarm was subjected to a cyber operation conducted by the threat group known as the People’s CyberArmy. The attack targeted the organization’s production infrastructure that supports medication development and phytochemical processing. Public disclosures did not specify the technical effects, duration of disruption, or any resulting operational downtime. The incident is cited as an illustration of broader interest by threat actors in pharmaceutical supply‑chain vulnerabilities. No information regarding parent‑company relationships, subsidiary structures, or exact employee numbers is provided in the available sources. Therefore, the profile is limited to the confirmed facts concerning the company’s activities, specialization, and the noted cyber event.